Morressier, the Berlin-based startup transforming scholarly communications, has announced it has attracted $16.5m in investment in a Series B round led by Molten Ventures and with the participation of existing investors including Redalpine, Owl Ventures, and Cherry Ventures. This growth investment follows the company’s Series A round communicated in May 2021, and will be topped up with further funding for acquisition opportunities.
Morressier counts some of the industry's leading players in the scientific ecosystem as customers, including: IOP Publishing, AAAS, ASCE, APS, and Mayo Clinic. The company will use its Series B growth capital for continued product innovation, scaling its go-to-market activities, including the institutional and corporate market, and to expand partnerships with leading research integrity vendors.
Morressier recently announced its Integrity Manager, designed to protect research integrity at every step of the publishing journey. The company already offers scientific researchers a suite of pre-submission checks to ensure submission completeness, quality, and help comply with industry standards. Integrity tools are also being developed into Journal Manager, a state-of-the-art journal submission system under development, with IOP Publishing on board as the first major client.
Research integrity threats are a growing and evolving issue, with a study showing 34% of neuroscience papers published in 2020 were likely made up or plagiarized. One in five articles published in journals may contain faked data produced by “paper mills” that are paid to fabricate scientific submissions, according to a study by German researchers who used new techniques to “red flag” problematic papers.
Morressier has been actively strengthening its team since the investment, attracting a wealth of experience into key roles at the executive level and across the team, with a number of recruitment processes ongoing.
Click here to read the original press release.
